Company launches Canadian drug plan cooperativeNew coalition enables organizations to improve corporate drug plan management to achieve immediate and long-term drug plan efficiencies and savings benefiting employees and employers B.C. legislation updates: Expanded scopes of practice for pharmacists and nurses, funding for primary care physicians Alberta legislation updates: Expanding the Primary Care Initiative; more pharmacists prescribing Accessing Quality Care Will interprofessional care teams help? Pharmacists stage last-minute rallies The patient-centred approach Rise in chronic disease brings the importance of selfcare into sharper focus N.B. legislation updates: Breaking down barriers to nursing; outlining requirements for pharmacist prescribing The government bailout of Calgary’s Health Resource Centre Isn’t the private sector supposed to be the saviour of our medicare system? The Healthcare Interview: Inside rural Ontario's drug reform struggle Rural Ontario pharmacy owner John Stanczyk on the fallout from drug reform and the move toward U.S.-style pharmacy First IL-6 receptor inhibitor for rheumatoid arthritis Hoffmann-La Roche will soon be introducing Actemra (tocilizumab), the first interleukin-6 (IL-6) receptor inhibitor to be approved for the treatment of rheumatoid arthritis (RA). First Previous 765 766 767 768 769 Next Last
